课题基金 / 基金详情

Targeted Drug Delivery to the Cornea of the Eye Via Medicated Contact Lenses and Mucoadhesive Thin Films

Targeted Drug Delivery to the Cornea of the Eye Via Medicated Contact Lenses and Mucoadhesive Thin Films
通过药用隐形眼镜和粘膜粘附薄膜将靶向药物递送至眼角膜
批准号:
BB/S004874/1
负责人:
Andrew Quantock
金额:
$65.18万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --

项目摘要

项目成果

Andrew Quantock的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A healthy cornea, the clear tissue at the front of the eye, is essential for vision. If it becomes infected or diseased, however, vision can be lost. Infection can occur because of viruses, parasites, fungi or bacteria, and the problem is serious. A bacterial infection of the eye called trachoma, as one example, is the world's leading cause of preventable blindness. It is highly contagious, with around 41 million people, mostly women and children in the developing world, infected. Traditionally, eye drops containing medicines are used to treat corneal disease or infection, but this is highly inefficient because the drug is immediately diluted by tears and most of the dose is washed away within a few blinks. Our research will develop drug-loaded contact lenses and purpose-made biodegradable thin films that can be applied to the eye for the effective and controlled-release delivery of disease-specific medications to the cornea to treat a wide range of potentially blinding conditions.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3390/pharmaceutics14081631
发表时间: 2022-08-04
期刊: PHARMACEUTICS
影响因子: 5.4
作者: [Wong, Anepmete, Fallon, Melissa, Celiksoy, Vildan, Ferla, Salvatore, Varricchio, Carmine, Whitaker, David, Quantock, Andrew J., Heard, Charles M.]
通讯作者: Heard, Charles M.
DOI: 10.1016/j.ijpharm.2020.120067
发表时间: 2021-01-05
期刊: INTERNATIONAL JOURNAL OF PHARMACEUTICS
影响因子: 5.8
作者: [Baba, Koichi, Hashida, Noriyasu, Nishida, Kohji]
通讯作者: Nishida, Kohji
Nanoscale Structural Characterisations of Ocular Tissues Derived from Human iPS Cells
  • 批准号:
    BB/X000966/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $90.95万
  • 财政年份:
    2023
  • 负责人:
    Andrew Quantock
  • 依托单位:
The Genomic Basis of Human Induced Pluripotent Stem (iPS) Cell Differentiation into Eye-Like Tissues.
  • 批准号:
    BB/S015981/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $62.28万
  • 财政年份:
    2019
  • 负责人:
    Andrew Quantock
  • 依托单位:
A mechanistic understanding of corneal pathobiology and the development of therapeutic strategies for the treatment of connective tissue disorders
  • 批准号:
    MR/S037829/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $246.93万
  • 财政年份:
    2019
  • 负责人:
    Andrew Quantock
  • 依托单位:
Japan Partnering Award: The Generation of Eye Tissues from Human Induced Pluripotent Stem (iPS) Cells.
  • 批准号:
    BB/R021244/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $6.11万
  • 财政年份:
    2018
  • 负责人:
    Andrew Quantock
  • 依托单位:
国内基金
海外基金
不同功能基团的电中性Drug-Free纳米颗粒的构建及克服肿瘤耐药的研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    杨胜彩
  • 依托单位:
Drug-ADR-Pathway复合网络构建及ADR分子机制研究
  • 批准号:
    61372188
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2013
  • 负责人:
    陈秀杰
  • 依托单位:
Drug-pHLA对接指纹图谱库的构建及HLA介导SADR的预测方法研究
  • 批准号:
    61073135
  • 项目类别:
    面上项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2010
  • 负责人:
    梅虎
  • 依托单位:
新型药物传输系统drug-LDHs 复合纳米粒子的可控制备及其微结构对缓控释性能的调控
  • 批准号:
    20776012
  • 项目类别:
    面上项目
  • 资助金额:
    31.0万元
  • 批准年份:
    2007
  • 负责人:
    张慧
  • 依托单位: